Other
Common Stock, Shares, Outstanding
Guardant Health Common Stock, Shares, Outstanding increased by 0.7% to $131.51M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.4%, from $123.65M to $131.51M. Over 5 years (FY 2020 to FY 2025), Common Stock, Shares, Outstanding shows an upward trend with a 5.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2017
Last reportedQ1 2026May 7, 2026
Metric ID:
other_common_stock_shares_outstandingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $101.27M | $101.62M | $101.77M | $101.9M | $102.19M | $102.41M | $102.62M | $102.71M | $117.66M | $117.85M | $121.63M | $121.79M | $122.97M | $123.16M | $123.99M | $123.65M | $124.48M | $125.01M | $130.64M | $131.51M |
| QoQ Change | — | +0.4% | +0.1% | +0.1% | +0.3% | +0.2% | +0.2% | +0.1% | +14.6% | +0.2% | +3.2% | +0.1% | +1.0% | +0.2% | +0.7% | -0.3% | +0.7% | +0.4% | +4.5% | +0.7% |
| YoY Change | — | — | — | — | +0.9% | +0.8% | +0.8% | +0.8% | +15.1% | +15.1% | +18.5% | +18.6% | +4.5% | +4.5% | +1.9% | +1.5% | +1.2% | +1.5% | +5.4% | +6.4% |
Range$101.27M – $131.51M
CAGR+5.7%
Avg YoY Growth+6.1%
Median YoY Growth+3.2%
Current Streak4 quarters growth
Common Stock, Shares, Outstanding at Other Companies
Frequently Asked Questions
- What is Guardant Health's common stock, shares, outstanding?
- Guardant Health (GH) reported common stock, shares, outstanding of $131.51M in Q1 2026.
- How has Guardant Health's common stock, shares, outstanding changed year-over-year?
- Guardant Health's common stock, shares, outstanding increased by 6.4% year-over-year, from $123.65M to $131.51M.
- What is the long-term trend for Guardant Health's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Guardant Health's common stock, shares, outstanding has grown at a 5.4% compound annual growth rate (CAGR), from $100.21M to $130.64M.